Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | -4.35% |
|
-12.00% | -15.38% |
| Market Cap | 41.54M 29.48M 25.86M 23.9M 21.98M 2.84B 42.18M 286M 112M 1.39B 111M 108M 4.79B | P/E 2026 * |
-3.67x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 41.54M 29.48M 25.86M 23.9M 21.98M 2.84B 42.18M 286M 112M 1.39B 111M 108M 4.79B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.31x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -4.35% | ||
| 1 week | -12.00% | ||
| Current month | -18.52% | ||
| 1 month | -26.67% | ||
| 3 months | -40.54% | ||
| 6 months | -29.03% | ||
| Current year | -15.38% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.16 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.21 |
| 3 years | 0.1 | | 0.97 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/5/26 | Option | Director | 260,000 | 0.0748% | ||
| 22/5/26 | Option | Chairman | 228,912 | 0.0658% | ||
| 22/5/26 | Option | Director | 166,482 | 0.0479% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.35% | -12.00% | -35.29% | -88.42% | 31M | |
| -0.23% | -3.23% | -18.04% | +8.37% | 123B | |
| -1.13% | -0.18% | +1.16% | -4.73% | 13.03B | |
| -0.87% | +1.79% | +59.12% | +100.88% | 9.21B | |
| +1.67% | +14.29% | -42.45% | -67.47% | 4.47B | |
| +0.98% | +0.85% | +6.39% | +47.04% | 2.7B | |
| +0.80% | -6.61% | -22.01% | -30.66% | 1.62B | |
| +3.55% | +3.10% | -9.81% | -18.90% | 1.6B | |
| -0.85% | +4.23% | +2.09% | -58.82% | 1.56B | |
| Average | -0.05% | +1.65% | -6.54% | -12.52% | 17.43B | |
| Weighted average by Cap. | -0.23% | -1.62% | -11.95% | +9.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.55M 3.11M 2.88M 2.65M 342M 5.08M 34.37M 13.44M 168M 13.34M 13.04M 577M |
| Net income | -12.83M -9.1M -7.98M -7.38M -6.79M -878M -13.03M -88.18M -34.49M -430M -34.21M -33.46M -1.48B | -19.77M -14.03M -12.31M -11.38M -10.46M -1.35B -20.08M -136M -53.16M -663M -52.73M -51.58M -2.28B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | CA$0.1100 | -4.35% | 25,201 |
| 17/07/26 | CA$0.1150 | +4.55% | 330,414 |
| 16/07/26 | CA$0.1100 | -4.35% | 101,650 |
| 15/07/26 | CA$0.1150 | 0.00% | 108,729 |
| 14/07/26 | CA$0.1150 | +9.52% | 683,235 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1150CAD
Average target price
0.4500CAD
Spread / Average Target
+291.30%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
